Thu, November 10, 2022
Wed, November 9, 2022
Tue, November 8, 2022
Mon, November 7, 2022

Derek Archila Maintained (CCCC) at Hold with Decreased Target to $11 on, Nov 8th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-11-on-nov-8th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Derek Archila of Wells Fargo, Maintained "C4 Therapeutics, Inc." (CCCC) at Hold with Decreased Target from $12 to $11 on, Nov 8th, 2022.

Derek has made no other calls on CCCC in the last 4 months.



There are 2 other peers that have a rating on CCCC. Out of the 2 peers that are also analyzing CCCC, 1 agrees with Derek's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Eric Joseph of "JP Morgan" Downgraded from Buy to Hold and Decreased Target to $15 on, Friday, November 4th, 2022


This is the rating of the analyst that currently disagrees with Derek


  • Terence Flynn of "Morgan Stanley" Initiated at Sell and Held Target at $6 on, Tuesday, October 11th, 2022

Publication Contributing Sources